ES2061518T3 - Compuestos que tienen propiedades antitumorales y antibacterianas. - Google Patents

Compuestos que tienen propiedades antitumorales y antibacterianas.

Info

Publication number
ES2061518T3
ES2061518T3 ES87311274T ES87311274T ES2061518T3 ES 2061518 T3 ES2061518 T3 ES 2061518T3 ES 87311274 T ES87311274 T ES 87311274T ES 87311274 T ES87311274 T ES 87311274T ES 2061518 T3 ES2061518 T3 ES 2061518T3
Authority
ES
Spain
Prior art keywords
antibacterial properties
represent
lower alkyl
groups
antitumoral
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES87311274T
Other languages
English (en)
Inventor
William Alexander Denny
Bruce Charles Baguley
Graham John Atwell
Gordon William Rewcastle
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Warner Lambert Co LLC
Original Assignee
Warner Lambert Co LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co LLC filed Critical Warner Lambert Co LLC
Application granted granted Critical
Publication of ES2061518T3 publication Critical patent/ES2061518T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/78—Ring systems having three or more relevant rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/78—Ring systems having three or more relevant rings
    • C07D311/80—Dibenzopyrans; Hydrogenated dibenzopyrans
    • C07D311/82—Xanthenes
    • C07D311/84—Xanthenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 9
    • C07D311/86—Oxygen atoms, e.g. xanthones

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

LA INVENCION SE REFIERE A UNA NUEVA CLASE DE ACIDOS XANTENON-4ACETICOS REPRESENTADOS POR LA FORMULA GENERAL (I), DONDE R1 REPRESENTA HASTA DOS GRUPOS: ALQUILO DE CADENA CORTA, HALOGENO, CF3, CN, NO2, NH2, CH3COOH, OR2, OH, NHCOR, NHSO2R2, SR2, SO2R2, CH2CONHR2 O NHR2 (SIENDO R2 UN ALQUILO DE CADENA CORTA QUE PUEDE ESTAR SUSTITUIDO CON FUNCIONES HIDROXI, AMINO O METOXI), EN CUALQUIERA DE LAS POSICIONES 1 A 8 DISPONIBLES, R1 PUEDE TAMBIEN REPRESENTAR LA SUSTITUICION DE UN GRUPO AZA (-N=) POR UNO O DOS GRUPOS METINO EN LOS ANILLOS CARBOCICLICOS Y LOS DOS R1 O DOS CUALESQUIERA DE LAS POSICIONES ADYACENTES PUEDEN TAMBIEN REPRESNETAR EL GRUPO -CH=CH-CH=CH-, PARA FORMAR UN BENCENO CONDENSADO ADICIONAL. TAMBIEN SE REFIERE LA ENVINCION A LAS SALES DE ADICION BASICAS DE ESTOS COMPUESTOS, LOS CUALES POSEEN PROPIEDADES ANTITUMORALES Y ANTIBACTERIANAS.
ES87311274T 1986-12-23 1987-12-22 Compuestos que tienen propiedades antitumorales y antibacterianas. Expired - Lifetime ES2061518T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NZ21878186 1986-12-23

Publications (1)

Publication Number Publication Date
ES2061518T3 true ES2061518T3 (es) 1994-12-16

Family

ID=19921928

Family Applications (1)

Application Number Title Priority Date Filing Date
ES87311274T Expired - Lifetime ES2061518T3 (es) 1986-12-23 1987-12-22 Compuestos que tienen propiedades antitumorales y antibacterianas.

Country Status (6)

Country Link
EP (1) EP0278176B1 (es)
JP (1) JP2672101B2 (es)
AT (1) ATE102616T1 (es)
DE (1) DE3789299T2 (es)
ES (1) ES2061518T3 (es)
HK (1) HK1000801A1 (es)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5116954A (en) * 1988-04-06 1992-05-26 Lipha, Lyonnaise Industrielle Pharmaceutique Pharmaceutically useful flavonoic compounds containing at least one substituent on the benzopyranone ring moiety
USH1427H (en) * 1988-04-06 1995-04-04 Briet; Phillipe Substituted flavonoid compounds, their salts, their manufacture and their use in combination with interleukin-2
US5238954A (en) * 1989-01-19 1993-08-24 The Upjohn Company Fluorinated flavone acetic acid
US4996230A (en) * 1990-02-16 1991-02-26 Eli Lilly And Company Leukotriene antagonists
JP2554447B2 (ja) * 1993-09-14 1996-11-13 ナショナル・サイエンス・カウンシル 新規キサントン化合物
AU5717400A (en) * 1999-06-14 2001-01-02 Cancer Research Ventures Limited Cancer therapy
JP2001247459A (ja) * 2000-03-03 2001-09-11 Oakland Uniservices Ltd 癌の組み合わせ療法
AU2001282717A1 (en) 2000-07-28 2002-02-13 Cancer Research Technology Limited Cancer treatment by combination therapy
KR20030018214A (ko) * 2001-08-27 2003-03-06 한국생명공학연구원 혈관 신생 저해제용 잔테논계 유도체 및 그를 포함하는혈관 신생 저해 조성물
GB0121285D0 (en) 2001-09-03 2001-10-24 Cancer Res Ventures Ltd Anti-cancer combinations
GB2386836B (en) 2002-03-22 2006-07-26 Cancer Res Ventures Ltd Anti-cancer combinations
GB2394658A (en) * 2002-11-01 2004-05-05 Cancer Rec Tech Ltd Oral anti-cancer composition
WO2008048117A2 (en) * 2006-10-17 2008-04-24 Auckland Uniservices Limited Synthesis of 5,6-dimethyl-9-oxo-9h-xanthen-4-yl- acetic acid (dmxaa)
CN101195609B (zh) * 2007-09-28 2011-04-20 武汉远大制药集团有限公司 5,6-二甲基呫吨酮-4-乙酸的制备方法及由此方法制备的衍生物和药物制剂
CN101914084B (zh) * 2010-07-30 2012-10-17 中国人民解放军第二军医大学 双苯吡喃酮氮杂环衍生物及其制备方法与应用
CN102786509B (zh) * 2011-05-16 2016-06-01 杭州民生药业有限公司 2-(5,6-二甲基呫吨酮-4-基)-乙酸的衍生物及其制备方法和用途
EP3535243B1 (en) 2016-11-04 2021-12-15 Auckland Uniservices Limited Substituted 9h-xanthen-9-one, 9h-thioxanthen-9-one and acridin-9(10h)-one derivatives and related compounds csf-1r inhibitors for the treatment of cancer
CN106977489B (zh) * 2017-04-20 2019-05-31 清华大学 一种制备多取代占吨酮类衍生物的方法

Also Published As

Publication number Publication date
JP2672101B2 (ja) 1997-11-05
EP0278176A3 (en) 1990-03-28
EP0278176B1 (en) 1994-03-09
JPS63295570A (ja) 1988-12-01
DE3789299T2 (de) 1994-08-04
DE3789299D1 (de) 1994-04-14
EP0278176A2 (en) 1988-08-17
ATE102616T1 (de) 1994-03-15
HK1000801A1 (en) 1998-05-01

Similar Documents

Publication Publication Date Title
ES2061518T3 (es) Compuestos que tienen propiedades antitumorales y antibacterianas.
FR2361339A1 (fr) Bis-aminophenoxy-2,2'biphenyles et leur application a la preparation de polyamides, de polyamides-imides et de poly-imides
FI931250A0 (fi) Sulfonamido- och sulfonamidokarbonyl-pyridin-2-karboxylsyraamider och deras pyridin-n-oxider, foerfarande foer deras framstaellning och deras anvaendning som laekemedel
FR2636338B1 (fr) Diorganopolysiloxane a fonction benzalmalonate
DE68901958D1 (de) Kontrastmittel mit stabilen, freien radikalen.
DE59403757D1 (de) Neue Chinolon- und Naphthyridoncarbonsäurederivate
DK0459256T3 (da) Oxazolidiononer
DE69031959D1 (de) Phenylalkan(en)-Säuren mit Leukotriene B4 antagonistischer Wirkung
BE820227A (fr) Derives d'acides bis-(triazinylamino)-stilbene-disulfoniques utilisables comme azureurs optiques
ATE93853T1 (de) Substituierte chinolinderivate.
GB1398993A (en) Triazolyl-styryl compounds
ATE27452T1 (de) Substituierte o-phenylendiaminderivate.
MX163460B (es) Procedimiento para la preparacion de diazaoxaespirodecanos substituidos y empleo como estabilizadores para polimeros
FR2373551A1 (fr) Esters phosphores fluores ampholytes, leur preparation et leur utilisation comme surfactifs
FI893460A0 (fi) Anvaendning av substituerade 3,4-dihydro -2h-bensopyraner som laekemedel mot funktionsstoerningar vilka tilltaepper lungorna, och/eller stoerningar i de avledande urinroeren.
FI892681A0 (fi) Nya jodade icke-joniska trijodbenzenfoereningar och dessa innehaollande kontrastmedel.
DE3772403D1 (de) Zitronensaeurederivate als emulgatoren fuer die emulsationspolymerisation.
ES2127191T3 (es) Derivados de diamino-s-triazinona.
ATE80149T1 (de) Aminophenylalkylendiamine und deren verwendung in oxidationshaarfaerbemitteln.
FR2375188A1 (fr) Pour : nitro-amines utilisables comme composantes de diazotation
FR2364214A2 (fr) Benzimidazo-(1,2-a)-quinoleines et leur preparation
SE7713968L (sv) Basiskt alkylerade ditiosalicylsyraamider, sett for framstellning derav samt anvendning derav som lekemedel
DK0433239T3 (da) Anvendelse af naphthoxaziner
SU145910A1 (ru) Электромеханический генератор автоколебаний
JPS5279731A (en) Optical reader

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 278176

Country of ref document: ES